Overview

Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori

Status:
Unknown status
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
Patients infected with H. pylori are treated with the individualized regimen which is based on the mutation of 23S rRNA of H. pylori.
Phase:
Phase 2
Details
Lead Sponsor:
Hamamatsu University
Treatments:
Amoxicillin
Clarithromycin